Competitive Landscape by Indication
Data updated: May 20, 2026
151 indications, 114,245 trials mapped
Oncology
53,941 trialsSolid Tumor (Advanced)
9364 trials
858 Ph3
Merck, Eli Lilly, Johnson & Johnson
Breast Cancer
3886 trials
697 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
3837 trials
342 Ph3
Roche, Merck, Genmab
NSCLC
3329 trials
541 Ph3
AstraZeneca, Merck, Roche
Colorectal Cancer
2540 trials
357 Ph3
AbbVie, AstraZeneca, Revolution Medicines, Inc.
Prostate Cancer
2260 trials
345 Ph3
Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.
Multiple Myeloma
1900 trials
226 Ph3
Johnson & Johnson, GSK, AbbVie
AML
1782 trials
165 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Hematologic Malignancies
1702 trials
149 Ph3
Johnson & Johnson, Novartis, Orca Biosystems, Inc.
Melanoma
1641 trials
138 Ph3
Merck, Bristol-Myers Squibb, Novartis
Pancreatic Cancer
1539 trials
133 Ph3
Revolution Medicines, Inc., AstraZeneca, Astellas Pharma Global Development, Inc.
Hepatocellular Carcinoma
1396 trials
215 Ph3
AstraZeneca, Roche, Akeso
Ovarian Cancer
1365 trials
158 Ph3
AstraZeneca, AbbVie, Merck
Lung Cancer (General)
1289 trials
166 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Head and Neck Cancer
1206 trials
111 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Rakuten Medical, Inc.
MDS
1170 trials
94 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Gastric Cancer
1057 trials
182 Ph3
AstraZeneca, Astellas Pharma Global Development, Inc., Chongqing Precision Biotech Co., Ltd
Sarcoma
1026 trials
72 Ph3
USWM CT, LLC, Hansoh BioMedical R&D Company, Eli Lilly
Glioblastoma
964 trials
63 Ph3
Novartis, GT Medical Technologies, Inc., Philogen S.p.A.
Bladder Cancer
959 trials
135 Ph3
Merck, AstraZeneca, Pfizer
ALL
929 trials
90 Ph3
Novartis, Amgen, Chongqing Precision Biotech Co., Ltd
Brain Tumor
781 trials
55 Ph3
Pfizer, InSightec, Jazz Pharmaceuticals
Esophageal Cancer
772 trials
130 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
CLL
767 trials
82 Ph3
BeOne Medicines, Acerta Pharma BV, AbbVie
Renal Cell Carcinoma
759 trials
71 Ph3
Merck, Bristol-Myers Squibb, Exelixis
Squamous Cell Carcinoma
630 trials
62 Ph3
Regeneron, Merck, Replimune, Inc.
Triple Negative Breast Cancer
584 trials
65 Ph3
Gilead, Novartis, AstraZeneca
Cholangiocarcinoma
567 trials
58 Ph3
AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly
SCLC
548 trials
69 Ph3
Amgen, Boehringer Ingelheim, Merck
Cervical Cancer
520 trials
88 Ph3
AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.
Hodgkin Lymphoma
475 trials
36 Ph3
Merck, Takeda, Tessa Therapeutics
Endometrial Cancer
448 trials
48 Ph3
AstraZeneca, Merck, Genmab
CML
397 trials
44 Ph3
Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Neuroendocrine Tumors
322 trials
41 Ph3
Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Jiangsu HengRui Medicine Co., Ltd.
Myelofibrosis
278 trials
34 Ph3
Novartis, Bristol-Myers Squibb, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Mesothelioma
275 trials
17 Ph3
Novartis, AstraZeneca, Seagen, a wholly owned subsidiary of Pfizer
Thyroid Cancer
223 trials
33 Ph3
Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
182 trials
31 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals
HER2- Breast Cancer
171 trials
18 Ph3
AstraZeneca, Novartis, BeOne Medicines
Merkel Cell Carcinoma
101 trials
6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., AstraZeneca
CNS
10,308 trialsMajor Depression
1753 trials
471 Ph3
Neurocrine Biosciences, Johnson & Johnson, Neumora Therapeutics, Inc.
Alzheimer's Disease
1507 trials
288 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Schizophrenia
936 trials
252 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Parkinson's Disease
916 trials
171 Ph3
iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.
Multiple Sclerosis
856 trials
233 Ph3
Roche, Novartis, Sanofi
Migraine
502 trials
191 Ph3
AbbVie, Pfizer, H. Lundbeck A/S
Epilepsy
459 trials
167 Ph3
Praxis Precision Medicines, UCB Biopharma SRL, SK Life Science, Inc.
Anxiety
457 trials
104 Ph3
VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd, Definium Therapeutics US, Inc.
Alcohol Use Disorder
443 trials
71 Ph3
Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.
Opioid Use Disorder
423 trials
90 Ph3
Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly
ALS
343 trials
71 Ph3
Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.
Autism Spectrum Disorder
331 trials
63 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark
ADHD
331 trials
117 Ph3
Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim, Bazelet Nehushtan LtD.
PTSD
305 trials
61 Ph3
Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.
Bipolar Disorder
284 trials
94 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.
Neuropathy
274 trials
70 Ph3
argenx, WinSanTor, Inc, Rinri Therapeutics
Huntington's Disease
104 trials
17 Ph3
Roche, Skyhawk Therapeutics, Inc., Novartis
OCD
84 trials
11 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche
Infectious Disease
9,891 trialsHIV
2254 trials
440 Ph3
ViiV Healthcare, Gilead, Merck
COVID-19
2239 trials
739 Ph3
BioNTech SE, Novavax, Pfizer
Influenza
1166 trials
326 Ph3
GSK, Changchun BCHT Biotechnology Co., Sanofi
Hepatitis C
1012 trials
293 Ph3
Atea Pharmaceuticals, Inc., Gilead, Merck
Hepatitis B
620 trials
108 Ph3
Ausper Biopharma Co., Ltd., Beijing Continent Pharmaceutical Co, Ltd., GSK
Malaria
595 trials
129 Ph3
GSK, Sanaria Inc., Novartis
Sepsis
484 trials
159 Ph3
Bayer, AstraZeneca, ImmunityBio, Inc.
Tuberculosis
470 trials
115 Ph3
Shanghai Jiatan Pharmatech Co., Ltd, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc.
RSV
281 trials
68 Ph3
GSK, ModernaTX, Inc., Shenzhen Shenxin Biotechnology Co., Ltd
Fungal Infections
220 trials
68 Ph3
Merck, F2G Biotech GmbH, Basilea Pharmaceutica
H. pylori
203 trials
48 Ph3
ARJ Medical, Inc., Catalysis SL, TenNor Therapeutics (Suzhou) Limited
C. difficile
175 trials
45 Ph3
AstraZeneca, Vedanta Biosciences, Inc., Acurx Pharmaceuticals Inc.
Bacterial Infections
172 trials
35 Ph3
Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.
Metabolic
8,800 trialsType 2 Diabetes
2699 trials
826 Ph3
Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity
1688 trials
380 Ph3
Eli Lilly, Novo Nordisk, Amgen
Diabetes (General)
1605 trials
405 Ph3
Gan & Lee Pharmaceuticals., Novo Nordisk, Jiangsu HengRui Medicine Co., Ltd.
Type 1 Diabetes
806 trials
178 Ph3
Eli Lilly, Sanofi, Novo Nordisk
Dyslipidemia
719 trials
278 Ph3
Addpharma Inc., Qilu Pharmaceutical Co., Ltd., Novartis
NASH/NAFLD
676 trials
105 Ph3
GSK, Akero Therapeutics, Inc, Corcept Therapeutics
Diabetic Complications
607 trials
137 Ph3
Roche, EyeBiotech Ltd., Regeneron
Cardiovascular
6,876 trialsHypertension
2131 trials
622 Ph3
Boryung Pharmaceutical Co., Ltd, Addpharma Inc., Merck
Heart Failure
1181 trials
278 Ph3
Novo Nordisk, HELP Therapeutics Co., Ltd., AstraZeneca
Stroke
1137 trials
384 Ph3
Tisento Therapeutics, Shin Poong Pharmaceutical Co. Ltd., NoNO Inc.
Coronary Artery Disease
1053 trials
235 Ph3
Novartis, XyloCor Therapeutics, Inc., Beijing Inno Medicine Co., Ltd.
Myocardial Infarction
484 trials
138 Ph3
Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd.
Atrial Fibrillation
479 trials
143 Ph3
Anthos Therapeutics, Inc., Regeneron, Novartis
Thrombosis
273 trials
119 Ph3
Regeneron, Boston Scientific Corporation, Supergene, LLC
Arrhythmia
83 trials
28 Ph3
Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals
Hypertrophic Cardiomyopathy
55 trials
18 Ph3
Shandong Suncadia Medicine Co., Ltd., Cytokinetics, Bristol-Myers Squibb
Immunology
5,001 trialsRheumatoid Arthritis
1067 trials
288 Ph3
Eli Lilly, AstraZeneca, Bristol-Myers Squibb
Psoriasis
1019 trials
328 Ph3
Johnson & Johnson, Bristol-Myers Squibb, UCB Biopharma SRL
Atopic Dermatitis
812 trials
206 Ph3
Pfizer, AbbVie, Guangdong Hengrui Pharmaceutical Co., Ltd
Lupus
636 trials
103 Ph3
Novartis, AstraZeneca, Bristol-Myers Squibb
Crohn's Disease
524 trials
151 Ph3
Takeda, Johnson & Johnson, AbbVie
Ulcerative Colitis
522 trials
128 Ph3
Takeda, Eli Lilly, AbbVie
Psoriatic Arthritis
184 trials
80 Ph3
UCB Biopharma SRL, AbbVie, Bristol-Myers Squibb
Ankylosing Spondylitis
135 trials
45 Ph3
UCB Biopharma SRL, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Jiangsu vcare pharmaceutical technology co., LTD
IBD
102 trials
25 Ph3
Disc Medicine, Inc, iCell Gene Therapeutics, Parvus Therapeutics, Inc.
Pain
4,445 trialsAcute Pain
2754 trials
762 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Postoperative Pain
1086 trials
235 Ph3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Pacira Pharmaceuticals, Inc, Haisco Pharmaceutical Group Co., Ltd.
Neuropathic Pain
317 trials
53 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.
Chronic Pain
288 trials
74 Ph3
Evon Medics LLC, iN Therapeutics Co., Ltd., Ethos Research & Development
Respiratory
4,256 trialsAsthma
1419 trials
382 Ph3
AstraZeneca, GSK, Sanofi
COPD
1171 trials
346 Ph3
AstraZeneca, GSK, Sanofi
Pneumonia
514 trials
181 Ph3
GSK, Qilu Pharmaceutical Co., Ltd., Pfizer
Cystic Fibrosis
480 trials
132 Ph3
Vertex Pharmaceuticals Incorporated, Sionna Therapeutics Inc., Boehringer Ingelheim
Allergic Rhinitis
369 trials
137 Ph3
Genrix (Shanghai) Biopharmaceutical Co., Ltd., Prime Gene Therapeutics Co., Ltd., ALK-Abelló A/S
Idiopathic Pulmonary Fibrosis
303 trials
53 Ph3
Boehringer Ingelheim, Bristol-Myers Squibb, Sunshine Lake Pharma Co., Ltd.
Musculoskeletal
1,733 trialsOsteoarthritis
1044 trials
282 Ph3
Eli Lilly, Pacira Pharmaceuticals, Inc, TBF Genie Tissulaire
Osteoporosis
368 trials
101 Ph3
Amgen, Shenzhen Salubris Pharmaceuticals Co., Ltd., Qilu Pharmaceutical Co., Ltd.
Gout
227 trials
52 Ph3
Crystalys Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd
Muscle Spasm
94 trials
45 Ph3
Chongqing Claruvis Pharmaceutical Co., Ltd., Ipsen, Merz Pharmaceuticals GmbH
Ophthalmology
1,532 trialsGastrointestinal
1,400 trialsNausea/Vomiting
382 trials
119 Ph3
Helsinn Healthcare SA, Eli Lilly, Vanda Pharmaceuticals
Peptic Ulcer
358 trials
96 Ph3
Cellution Biologics, TR Therapeutics, Applied Biologics, LLC
Constipation
294 trials
110 Ph3
Ardelyx, Shionogi, Eli Lilly
Diarrhea
220 trials
62 Ph3
Bausch Health Americas, Inc., Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd
GERD
146 trials
45 Ph3
Cinclus Pharma Holding AB, Takeda, Addpharma Inc.
Rare Disease
1,374 trialsSickle Cell Disease
364 trials
70 Ph3
Novartis, Forma Therapeutics, Inc., Vertex Pharmaceuticals Incorporated
Immune Thrombocytopenia
358 trials
109 Ph3
Novartis, argenx, Jiangsu HengRui Medicine Co., Ltd.
Hemophilia
287 trials
126 Ph3
Pfizer, Roche, CSL Behring
Duchenne Muscular Dystrophy
160 trials
35 Ph3
Sarepta Therapeutics, Inc., NS Pharma, Inc., Italfarmaco
Spinal Muscular Atrophy
61 trials
22 Ph3
GeneCradle Inc, Biogen, Roche
Fabry Disease
61 trials
28 Ph3
Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Sanofi
Gaucher Disease
50 trials
18 Ph3
Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company
Mastocytosis
28 trials
5 Ph3
Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics
CDKL5 Deficiency Disorder
5 trials
3 Ph3
Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals
Women's Health
1,066 trialsInfertility
481 trials
162 Ph3
IBSA Institut Biochimique SA, Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas
PCOS
198 trials
59 Ph3
Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., Dexa Medica Group
Menopause
181 trials
49 Ph3
Bayer, Astellas Pharma Global Development, Inc., AbCellera Biologics Inc.
Endometriosis
159 trials
44 Ph3
AbbVie, Kissei Pharmaceutical Co., Ltd., Hope Medicine (Nanjing) Co., Ltd
Contraception
47 trials
13 Ph3
YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences
Renal
1,048 trialsDermatology
934 trialsAcne
392 trials
112 Ph3
AbbVie, Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Alopecia
251 trials
62 Ph3
Applied Biology, Inc., Veradermics, Inc., Pfizer
Rosacea
124 trials
39 Ph3
Tarsus Pharmaceuticals, Inc., Galderma R&D, LEO Pharma
Vitiligo
109 trials
31 Ph3
Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.
Skin Infections
58 trials
16 Ph3
GSK, Melinta Therapeutics, Inc., Durata Therapeutics Inc., an affiliate of Allergan plc
Urology
634 trialsHepatology
429 trialsSleep
335 trialsEndocrine
242 trialsGrowth Hormone Deficiency
97 trials
35 Ph3
Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Xiamen Amoytop Biotech Co., Ltd.
Acromegaly
48 trials
16 Ph3
Crinetics Pharmaceuticals Inc., Debiopharm International SA, AstraZeneca
Hypothyroidism
41 trials
10 Ph3
AbbVie, IBSA Institut Biochimique SA, Neuvosyn Laboratories, LLC
Adrenal Insufficiency
30 trials
6 Ph3
Neurocrine UK Limited
Hyperthyroidism
26 trials
7 Ph3
argenx, Biohaven Therapeutics Ltd., Merida Biosciences
Click any indication to see full competitive landscape (all sponsors, trials, phases).
Data: ClinicalTrials.gov | Mapping: Indication Taxonomy